6.
Shuai H, Chan J, Hu B, Chai Y, Yoon C, Liu H
. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5. EBioMedicine. 2023; 95:104753.
PMC: 10448076.
DOI: 10.1016/j.ebiom.2023.104753.
View
7.
Schoggins J, Wilson S, Panis M, Murphy M, Jones C, Bieniasz P
. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011; 472(7344):481-5.
PMC: 3409588.
DOI: 10.1038/nature09907.
View
8.
Thorne L, Bouhaddou M, Reuschl A, Zuliani-Alvarez L, Polacco B, Pelin A
. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2021; 602(7897):487-495.
PMC: 8850198.
DOI: 10.1038/s41586-021-04352-y.
View
9.
Channappanavar R, Fehr A, Zheng J, Wohlford-Lenane C, Abrahante J, Mack M
. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019; 129(9):3625-3639.
PMC: 6715373.
DOI: 10.1172/JCI126363.
View
10.
Strayer D, Dickey R, Carter W
. Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans. Infect Disord Drug Targets. 2014; 14(1):37-43.
DOI: 10.2174/1871526514666140713152858.
View
11.
Comar C, Otter C, Pfannenstiel J, Doerger E, Renner D, Tan L
. MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells. Proc Natl Acad Sci U S A. 2022; 119(21):e2123208119.
PMC: 9173776.
DOI: 10.1073/pnas.2123208119.
View
12.
Metzler M, Tharyan R, Klann K, Grikscheit K, Bojkova D, Cinatl J
. SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells. Mol Cell Proteomics. 2023; 22(5):100537.
PMC: 10060015.
DOI: 10.1016/j.mcpro.2023.100537.
View
13.
Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S
. A brief review of influenza virus infection. J Med Virol. 2021; 93(8):4638-4646.
DOI: 10.1002/jmv.26990.
View
14.
Kim K, Jung J, Kang I, Choi Y, Kim S
. ROS Is Involved in Disruption of Tight Junctions of Human Nasal Epithelial Cells Induced by HRV16. Laryngoscope. 2018; 128(12):E393-E401.
DOI: 10.1002/lary.27510.
View
15.
Deng X, Hackbart M, Mettelman R, OBrien A, Mielech A, Yi G
. Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proc Natl Acad Sci U S A. 2017; 114(21):E4251-E4260.
PMC: 5448190.
DOI: 10.1073/pnas.1618310114.
View
16.
Khalafalla A, Lu X, Al-Mubarak A, Dalab A, Al-Busadah K, Erdman D
. MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013-2014. Emerg Infect Dis. 2015; 21(7):1153-8.
PMC: 4480395.
DOI: 10.3201/eid2107.150070.
View
17.
Ruan T, Sun Y, Zhang J, Sun J, Liu W, Prinz R
. H5N1 infection impairs the alveolar epithelial barrier through intercellular junction proteins via Itch-mediated proteasomal degradation. Commun Biol. 2022; 5(1):186.
PMC: 8888635.
DOI: 10.1038/s42003-022-03131-3.
View
18.
Laine L, Skon M, Vaisanen E, Julkunen I, Osterlund P
. SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant. Front Immunol. 2022; 13:1016108.
PMC: 9561549.
DOI: 10.3389/fimmu.2022.1016108.
View
19.
Lokugamage K, Hage A, de Vries M, Valero-Jimenez A, Schindewolf C, Dittmann M
. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. J Virol. 2020; 94(23).
PMC: 7654262.
DOI: 10.1128/JVI.01410-20.
View
20.
Hale B, Randall R, Ortin J, Jackson D
. The multifunctional NS1 protein of influenza A viruses. J Gen Virol. 2008; 89(Pt 10):2359-2376.
DOI: 10.1099/vir.0.2008/004606-0.
View